Suchergebnisse - (Person:"Wei, Xiang")

PubPharm (16)

1

Dual HER2 blockade therapy increases the risk of developing cardiac toxicities in HER2-positive breast cancer : An up-to-date comprehensive meta-analysis

enthalten in: The breast journal | 2021

von Qi, W. | Cao, L. | Xu, C. | +2

2

Risk of interstitial lung disease associated with EGFR-TKIs in advanced non-small-cell lung cancer : a meta-analysis of 24 phase III clinical trials

enthalten in: Journal of chemotherapy (Florence, Italy) | 2015

von Qi, W. | Sun, Y. | Shen, Z. | +1

3

Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer : a meta-analysis of 17 phase III randomized controlled trials

enthalten in: Current medical research and opinion | 2015

von Qi, W. | Fu, S. | Zhang, Q. | +1

4

Risk of anti-EGFR monoclonal antibody-related skin rash : an up-to-date meta-analysis of 25 randomized controlled trials

enthalten in: Journal of chemotherapy (Florence, Italy) | 2014

von Qi, W. | Sun, Y. | Shen, Z. | +1

5

Risk of gastrointestinal perforation in cancer patients treated with aflibercept : a systematic review and meta-analysis

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2014

von Qi, W. | Shen, F. | Qing, Z. | +1

6

Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors : an up-to-date meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2014

von Qi, W. | Shen, Z. | Tang, L. | +1

7

Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients : a systematic review and meta-analysis

enthalten in: BMC medicine | 2014

von Qi, W. | Fu, S. | Zhang, Q. | +1

CommentIn: BMC Med. 2015;13:37. - PMID 25857245

8

Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors : a systematic review and meta-analysis of 36 clinical trials

enthalten in: British journal of clinical pharmacology | 2014

von Qi, W. | Shen, Z. | Tang, L. | +1

9

Risk of hypertension in cancer patients treated with aflibercept : a systematic review and meta-analysis

enthalten in: Clinical drug investigation | 2014

von Qi, W. | Shen, Z. | Tang, L. | +1

10

Treatment-related mortality with aflibercept in cancer patients : a meta-analysis

enthalten in: European journal of clinical pharmacology | 2014

von Qi, W. | Tang, L. | Shen, Z. | +1

CommentIn: Eur J Clin Pharmacol. 2014 Oct;70(10):1269-70. - PMID 25055958